First-pass extracted concept

optogenetic control of membrane potential in tumorigenesis

Candidate: concept label1 source documents4 linked claims
Live refresh every 5sNext refresh in 5s

Aliases

optogenetic approach to dissect the biophysics of cancer

Evidence Snippets

Here we describe the first use of optogenetics to manipulate ion-flux mediated regulation of membrane potential specifically to prevent and cause regression of oncogene-induced tumors.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1disease modelsupports2016Source 1DOIPubMed

Injection of mutant-KRAS mRNA induces tumor-like structures with documented similarities to tumors in Xenopus tadpoles.

Quoted textsource-backed
Injection of mutant-KRAS mRNA induces tumor-like structures with many documented similarities to tumors, in Xenopus tadpoles.
Claim 2first usesupports2016Source 1DOIPubMed

This paper reports the first use of optogenetics to manipulate ion-flux-mediated membrane potential regulation to prevent and cause regression of oncogene-induced tumors.

Quoted textsource-backed
Here we describe the first use of optogenetics to manipulate ion-flux mediated regulation of membrane potential specifically to prevent and cause regression of oncogene-induced tumors.
Claim 3post formation interventionsupports2016Source 1DOIPubMed

Activation of co-expressed light-activated ion translocators after tumor formation significantly increases the frequency of tumor regression in a process called normalization.

Quoted textsource-backed
activation of co-expressed light-activated ion translocators after tumor formation significantly increases the frequency with which the tumors regress in a process called normalization
Claim 4proof of principlesupports2016Source 1DOIPubMed

The study provides proof-of-principle for interventions that regulate cell state by targeting physiological regulators that can override the presence of mutations.

Quoted textsource-backed
they provide proof-of-principle for a novel class of interventions, directed at regulating cell state by targeting physiological regulators that can over-ride the presence of mutations